Bidirectional arterial cannula for extracorporeal membrane oxygenation and method of using such a cannula
The bidirectional arterial cannula for ECMO addresses the issue of lower limb ischemia by enabling simultaneous retrograde and anterograde blood flow, ensuring efficient perfusion and simplifying cannula manipulation, thereby reducing complications.
Patent Information
- Application Number
- FR2019012831
- Authority / Receiving Office
- FR · FR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2019-11-18
- Publication Date
- 2024-11-29
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing ECMO procedures cause ischemia of the lower limb due to obstruction of the artery by the arterial cannula, necessitating a delicate and often random manipulation of a retro-perfusion cannula to divert blood flow to the limb, which is challenging and risky.
A bidirectional arterial cannula with a movable retro-perfusion cannula that can translate between retracted and deployed positions, allowing blood to be injected both retrogradely towards the heart and anterogradely towards the lower limb, minimizing the need for separate cannula manipulation and reducing the risk of ischemia and thrombosis.
The bidirectional cannula design ensures efficient blood flow to both the heart and lower limbs, avoiding ischemia and thrombosis while simplifying the cannula insertion process, reducing procedural complexity and complications.
Smart Images

Figure 00000018_0000 
Figure 00000018_0001 
Figure 00000018_0002
Abstract
Description
Title of the invention: Bidirectional arterial cannula for extracorporeal membrane oxygenation and method of using such a cannula technical field
[0001] The present invention relates to an arterial cannula for extracorporeal membrane oxygenation (ECMO) and a method of using such a cannula. Previous technique
[0002] Extracorporeal membrane oxygenation (ECMO) refers to an emergency circulatory support method for a patient suffering from cardiogenic shock. This method, in cases of acute circulatory failure, is used at the patient's bedside in the medical-surgical intensive care unit, regardless of the cause of heart failure. It is an extracorporeal circulation method, also used for open cardiac surgery. In the following description, we will refer more specifically to veno-arterial (VA) extracorporeal membrane oxygenation, which provides support to both the heart and lungs.
[0003] The objective of VA ECMO is to draw oxygen-poor blood from the patient's body, oxygenate it, and then reinject it into the patient's body. Blood is drawn from the right atrium (RA) of the patient's heart or from their inferior vena cava via a venous cannula, also called an intake cannula. It then passes through an oxygenator. Finally, it is reinjected retrogradely, that is, towards the heart, into the patient's iliac or femoral artery via an arterial cannula, also called a reinfusion cannula. A centrifugal pump rotating at a constant speed, on the order of 3000 rpm, enables this extracorporeal circulation of blood. The pump's rotation speed allows for variable flow rates adapted to the patient's needs.
[0004] The major drawback of this procedure is that lower limb ischemia occurs due to the lack of perfusion of the lower limb. Indeed, the arterial cannula obstructs the artery into which the blood is reinjected after oxygenation, thus preventing blood from flowing towards the lower limb. It is then necessary to divert some of the blood oxygenated by the oxygenator, sending it into the femoral artery towards the lower limb, that is, in the anterograde direction, downstream of the point of penetration of the arterial cannula relative to the anterograde direction of blood flow. This diversion is generally performed using a cannula or a retroperfusion catheter as illustrated in [Fig. 1]. This implies a delicate and often randomly performed manipulation, often with difficulty, to introduce the retroperfusion cannula into the femoral artery.
[0005] Figure 1 represents an arterial cannula 10 according to the prior art, comprising a main arterial cannula 12 and a retroperfusion cannula 14. The main arterial cannula 12 and retroperfusion cannula 14 each have a first end, 12' and 14' respectively, inserted into an artery 100 of a patient, such as the femoral artery, and are connected to each other by their opposite ends 10', to form the arterial cannula 10. The main arterial cannula 12 and retroperfusion cannula 14 are inserted into the artery 100 by means of introducing stylets (not shown) which dilate the artery. The stylets are then withdrawn to allow blood to flow into the main arterial cannula 12 and retroperfusion cannula 14.The retroperfusion cannula 14 is inserted into artery 100 at a downstream entry point "p", located downstream of an upstream entry point P of the main arterial cannula 12, relative to the anterograde direction of blood flow from the heart to the lower limbs, represented by arrow A. The arterial cannula 10 is connected to an oxygenator (not shown) to enable extracorporeal membrane oxygenation (ECMO). The oxygenator is itself connected to a venous cannula (not shown) which allows for the aspiration of blood S from the right atrium or the inferior vena cava (not shown) of the patient's heart. During ECMO, blood S flows from the venous cannula (not shown), into the oxygenator (not shown), and then in parallel through the main arterial cannula 12 and the retroperfusion cannula 14.From the main arterial cannula 12, blood is reinjected retrogradely, as indicated by arrow F, into artery 100, i.e., in the retrograde direction of flow, towards the iliac artery. From the retroperfusion cannula 14, blood is reinjected into artery 100, in the anterograde direction A, towards the lower limbs. Since the main arterial cannula 12 is occlusive to artery 100, the retroperfusion cannula 14 allows blood to be supplied to the lower limb.
[0006] The present invention aims in particular to resolve the aforementioned drawbacks. Description of the invention
[0007] The invention relates to an arterial cannula for ECMO comprising: - a main arterial cannula comprising an inner wall and having a first end with a blood outlet, the first end being intended to be inserted into an artery in order to inject blood retrogradely into the artery, and - a retroperfusion cannula configured to be mobile in translation between a retracted position in the first end of the arterial cannula main and a deployed position at least partially outside the first end of the main arterial cannula, opposite the blood outlet of the main arterial cannula.
[0008] Thus, the arterial cannula according to the invention makes it possible to inject blood into the artery in a retrograde manner, towards the heart, and in an anterograde manner, towards the lower limb, in order to avoid the risk of ischemia and thrombosis caused by ECMO, while avoiding a delicate operation of introducing a retroperfusion cannula into a femoral artery.
[0009] According to other features of the invention, the cannula of the invention comprises one or more of the following optional features considered alone or according to all possible combinations.
[0010] According to one feature, the main arterial cannula has an L-shaped form with a first branch corresponding to the first end intended to be introduced into the artery, and a second branch intended to cooperate with an oxygenator, the first branch and the second branch being connected by an elbow.
[0011] According to one feature, the elbow has an angle of curvature between 90° and 150°, and preferably 135°. In this way, the retroperfusion cannula is easily deployed out of the main arterial cannula.
[0012] According to one feature, the retroperfusion cannula comprises a tube with a diameter smaller than the diameter of the main arterial cannula and a ring with a diameter substantially identical to the diameter of the main arterial cannula, disposed at a proximal end of the retroperfusion cannula relative to the blood outlet of the main arterial cannula. Thus, the retroperfusion cannula is guided during its deployment from the main arterial cannula, and when the retroperfusion cannula is in the deployed position, it is retained to the main arterial cannula by its ring cooperating with the inner wall of the main arterial cannula, in order to prevent any misalignment or dislodgement that could lead to hemolysis or arterial trauma.
[0013] According to one feature, the retro-perfusion cannula is configured to slide in translation in contact with the inner wall of the main arterial cannula, until the ring comes into contact with a stop on the inner wall.
[0014] According to one feature, a cutout is present between the tube and the ring. This cutout is configured to cooperate with the bend of the main arterial cannula. Furthermore, this cutout can be configured to cooperate with an introduction stylet configured to induce the deployment of the retroperfusion cannula and to optimize blood flow in the main arterial cannula when the retroperfusion cannula is in the deployed position.
[0015] According to one feature, the tube has a distal end, opposite the ring, cut obliquely to fit the curve of the elbow of the main arterial cannula. Thus, in the withdrawn position, the distal end of the tube is complementary to the elbow and does not protrude from the elbow, either internally or externally, which allows the arterial cannula to slide easily out of the artery during its withdrawal.
[0016] According to one feature, the tube has a proximal end, near the cut, cut obliquely to match the curvature of the elbow of the main arterial cannula. Thus, in the deployed position, the proximal end of the tube is complementary to the elbow and does not protrude from the inside of the elbow, which allows for easy blood flow in the main arterial cannula.
[0017] According to one feature, the tube has an elliptical profile, i.e., an elliptical cross-section. Thus, the height and bulk of the retroperfusion cannula in the retracted position inside the first end of the main arterial cannula or in the deployed position in the artery are minimized.
[0018] According to one feature, the retroperfusion cannula tube has a surface area of approximately 3 to 3.5 mm², and preferably 3.15 mm², with a height of approximately 1 to 1.5 mm, and preferably 1.2 mm, and a width of approximately 3 to 3.5 mm, and preferably 3.34 mm. Thus, a minimum blood flow rate of 1 L / min is able to circulate through the tube. Such a flow rate is sufficient to prevent lower limb ischemia.
[0019] According to one feature, the ring has a convex inner wall. This facilitates the transition of the retroperfusion cannula from its deployed to its retracted position. Furthermore, this helps to flatten the blood flow and thus prevent hemolysis and turbulent flow.
[0020] According to one feature, the main arterial cannula has a longitudinal groove on its inner wall that cooperates with a rib on the ring of the retroperfusion cannula. This guides the translational movement of the retroperfusion cannula within the main arterial cannula. Furthermore, the groove acts as a stop for the rib during the translation of the retroperfusion cannula, ensuring that the ring remains in regular contact with the inner wall of the main arterial cannula without any protruding stop within the cannula, thus preventing turbulent flow and the risk of hemolysis.
[0021] According to one feature, the groove in the main arterial cannula has a length corresponding to the translation length of the retroperfusion cannula. Thus, the groove limits the translation of the retroperfusion cannula during the transition between the retracted and deployed positions.
[0022] Alternatively, the main arterial cannula has a translational portion of the ring at its first end, the translational portion having an internal diameter greater than the internal diameter of the rest of the main arterial cannula. Thus, the ring cooperates in translation with this translational portion and comes into contact with the rest of the main arterial cannula, which has a smaller diameter. Therefore, the translation of the retroperfusion cannula is limited by a stop effect of the ring provided by the difference in internal diameter of the main cannula, so that the distal end of the tube is flush with the bend when the retroperfusion cannula is in the retracted position, and the proximal end of the tube is flush with the bend in the extended position.
[0023] According to one feature, the main arterial cannula has a lumen in its wall opposite the blood outlet, preferably with a diameter substantially identical to the diameter of the retroperfusion cannula tube, to allow the tube to be deployed within the artery. Thus, the retroperfusion cannula is easily deployed from the main arterial cannula.
[0024] According to one feature, the lumen is arranged in the bend of the main arterial cannula.
[0025] According to one feature, the inner wall of the main arterial cannula, in contact with the retroperfusion cannula in the retracted position, is made of a rigid, biocompatible material, such as a metallic material or polycarbonate. Thus, the retroperfusion cannula is able to slide easily within the main arterial cannula without the latter being deformed during handling. Furthermore, the main arterial cannula is compact so as to minimize disruption to blood flow.
[0026] According to one feature, the main arterial cannula, apart from the inner wall in contact with the ring and the tube of the retroperfusion cannula, is made of a flexible material, such as nitinol or braided steel, preferably overmolded with a plastic material such as silicone or polyurethane. Thus, the main arterial cannula is atraumatic and is easily inserted into the artery.
[0027] Furthermore, the flexible material is capable of being deformed to allow the main arterial cannula to be shaped as desired, including a Z-shape with a first free branch corresponding to the first end intended to be inserted into the artery, a central branch, and a second free branch intended to cooperate with an oxygenator. This Z-shape reduces the overall size of the assembly and makes it easier to secure the cannula to the patient's skin, preventing cannula kinking.
[0028] According to one characteristic, the retroperfusion cannula has a wall thickness of approximately 1 mm maximum. Thus, the size is small.
[0029] According to one feature, the ring of the retroperfusion cannula is made of rigid plastic, such as polyurethane, or of biocompatible rigid metal such as steel. This optimizes the guidance of the retroperfusion cannula's translation.
[0030] According to one feature, the retroperfusion cannula tube is made of a metal- and plastic-based composite material at its proximal end and of a flexible plastic such as silicone at its distal end. Thus, the retroperfusion cannula is atraumatic at its distal end and non-deformable at its proximal end.
[0031] According to one feature, the tube and the ring are connected by a metallic insert forming the cutout, such as a steel strip. Thus, the retroperfusion cannula exhibits good mechanical resistance.
[0032] According to one feature, the first end of the main arterial cannula has at least one hole in its wall, near its blood outlet. Thus, blood can be drained in the event of obstruction of the outlet.
[0033] The invention further relates to an introduction stylet configured to be inserted into the arterial cannula as described above, in order to allow both the insertion of the main arterial cannula into the artery and the deployment of the retroperfusion cannula out of the main arterial cannula, the introduction stylet being configured to obstruct the main arterial cannula. Thus, no blood flow occurs while the introduction stylet is positioned in the main arterial cannula.
[0034] According to one feature, the introducing stylet is configured to be obstructive in the first branch of the main arterial cannula and non-obstructive in the elbow and the second branch of this main arterial cannula. Thus, when the elbow is positioned in the artery, blood is able to enter the main arterial cannula through the lumen in its wall opposite the blood outlet, and the blood is able to flow back up the second branch. An operator can then identify that the elbow is in the artery and therefore that the arterial cannula is correctly positioned.
[0035] According to one feature, the introduction stylet has a shape substantially complementary to the main arterial cannula with the retro-perfusion cannula in the retracted position.
[0036] The introducing stylet is configured to be inserted into the main arterial cannula, which has the retroperfusion cannula in the retracted position, without contacting the retroperfusion cannula tubing, and is configured to cooperate with the retroperfusion cannula ring to draw it into deployment upon withdrawal. Furthermore, the introducing stylet dilates the artery to facilitate the insertion of the main arterial cannula into the artery.
[0037] According to one feature, the introduction mandrel having a proximal end configured to be disposed in the first end of the main arterial cannula, the proximal end having a diameter increasing up to a diameter substantially identical to the diameter of the main arterial cannula, the proximal end being followed by a first intermediate portion of length at least greater than that of the retroperfusion cannula and of diameter less than the diameter of the main arterial cannula, the first intermediate portion being followed by a second intermediate portion of diameter substantially identical to that of the main arterial cannula.
[0038] According to one feature, the introduction stylet has a recess complementary to the cutout of the retroperfusion cannula, and the recess has a lug configured to drive the retroperfusion cannula in translation out of the arterial cannula when the introduction stylet is removed from the main arterial cannula.
[0039] According to one feature, the introduction stylet has a groove in which the ring is intended to fit. Thus, the retroperfusion cannula is able to be held in a retracted position within the main arterial cannula during insertion of the main arterial cannula into an artery, and able to be moved into its extended position during withdrawal of the introduction stylet from the arterial cannula.
[0040] According to one feature, the groove is complementary to the convex inner wall of the ring, so as to form a semi-elastic retention system when the convex inner wall of the ring is lodged in the groove of the introducing stylet. Thus, the retroperfusion cannula is able to be held in a retracted position within the main arterial cannula during insertion of the main arterial cannula into an artery, and able to be drawn into its extended position during withdrawal of the introducing stylet from the arterial cannula. When the ring reaches its abutment during the deployment of the retroperfusion cannula, the introducing stylet alone continues its translation due to a traction effect exerted on it by an operator.
[0041] According to one feature, the feed mandrel is axially perforated in its center into a hollow cylinder allowing the passage of a guide.
[0042] The invention also relates to a retraction mandrel configured to be inserted into the arterial cannula as described above, in order to allow the retro-perfusion cannula to be retracted into the main arterial cannula, and then to allow the main arterial cannula to be withdrawn from the artery, the retraction mandrel being configured to obstruct the main arterial cannula.
[0043] According to one feature, the retraction mandrel is axially perforated in its center into a hollow cylinder allowing the passage of a guide.
[0044] According to one feature, the retraction stylet includes a bulge configured to cooperate with the ring of the retroperfusion cannula in order to drive it in translation in the main arterial cannula, when it is inserted into the main arterial cannula.
[0045] The invention also relates to a kit comprising an arterial cannula, an introduction stylet and a withdrawal stylet, as described above. Brief description of the drawings
[0046] [Fig-1] Fig. 1 is a schematic view of a main arterial cannula and a retroperfusion cannula according to the prior art.
[0047] [Fig.2] Fig.2 represents an arterial cannula for ECMO according to the present exposed, in longitudinal section.
[0048] [Fig. 3] Fig. 3 is a schematic longitudinal cross-sectional view of part of the arterial cannula of the [Fig.2].
[0049] [Fig.4] Fig.4 is a schematic perspective view of a retro- cannula perfusion of the arterial cannula of the [Fig.2].
[0050] [Fig. 5] [Fig. 5] is a detailed view of [Fig. 3], illustrating the alignment between the retroperfusion cannula and the main arterial cannula when the retroperfusion cannula is in the deployed position.
[0051] [Fig. 6] [Fig. 6] is a schematic cross-sectional view of the cannula arterial including a retroperfusion cannula.
[0052] [Fig.7] Fig.7 is a schematic perspective view of a chuck introduction according to a first mode of implementation.
[0053] [Fig.8] Fig.8 is a schematic perspective view of a detail of a chuck introduction of [Fig.7].
[0054] [Fig.9] Fig.9 is a schematic cross-sectional view of the insertion mandrel of the [Fig.8], inserted into the ring of the retroperfusion cannula as described herein.
[0055] [Fig. 10] The [Fig. 10] is a schematic longitudinal sectional view of a portion of an arterial cannula fitted with an introduction stylet according to the [Fig.7].
[0056] [Fig. 11] [Fig. 11] is another schematic longitudinal cross-sectional view of the arterial cannula, illustrating an embodiment in which the main arterial cannula has a difference in internal diameter from [Fig. 10]
[0057] [Fig. 12] The [Fig. 12] is a partial schematic view of an infeed mandrel according to a second embodiment.
[0058] [Fig. 13] The [Fig. 13] is a schematic view of the introduction stylet of the [Fig.9] inserted into a retroperfusion cannula of an arterial cannula according to the present exposition.
[0059] [Fig. 14] The [Fig. 14] is a partial schematic view of the arterial cannula according to the present exposition, equipped with a retraction stylet inserted into the main cannula.
[0060] [Fig. 15] The [Fig. 15] is a schematic longitudinal sectional view of part of the arterial cannula of the [Fig. 14], detailing the retraction stylet.
[0061] [Fig. 16] The [Fig. 16] is a schematic perspective view of the retraction mandrel of figures 14 and 15. Description of the implementation methods
[0062] The [Fig.1] is described previously.
[0063] Figure [Fig. 2] illustrates an arterial cannula 20 according to the present exposition.
[0064] The arterial cannula 20 has a main arterial cannula 22 having a The first end 24 includes a blood outlet 26, and a second end 28 is intended to be connected to an oxygenator (not shown). The first end 24 and the second end 28 are connected by an elbow 27.
[0065] The main arterial cannula 22 has an L-shape, one branch of which corresponds to the first end 24 and the other branch corresponds to the second end 28. The elbow 27 has an average angle of curvature of 135° and can vary from 90° to 150°.
[0066] The first end 24 is configured to be inserted into an artery (not shown) in order to inject blood retrogradely along arrow F, into the artery. It includes a retroperfusion cannula 30 configured to be translationally mobile between a retracted position ([Fig. 6]) in the first end 24 of the main arterial cannula 22 and a deployed position ([Fig. 2]) in the artery, partially outside the main arterial cannula 22, opposite the blood outlet 26 of the main arterial cannula 22. The retroperfusion cannula 30 is intended to inject blood into the artery anterogradely, along arrow A.
[0067] The first end 24 of the main arterial cannula 22 is substantially straight, as is the retro-perfusion cannula 30.
[0068] The main arterial cannula 22 has at its proximal end to the blood outlet 26, a hole 29 allowing blood to be evacuated in case of occlusion of the outlet 26.
[0069] The main arterial cannula 22 is primarily made of nitinol or braided steel overmolded with silicone or polyurethane, and has a portion in contact with the retroperfusion cannula 30 in the retracted position, made of polycarbonate. Thus, it has a flexible part made of nitinol or steel, and a rigid part made of polycarbonate.
[0070] As illustrated in more detail in Figures 3 to 6, the retroperfusion cannula 30 comprises an elliptical tube 32, having, for example, a surface area of 3.15 mm2, a height "h" of 1.2 mm, a width L of 3.34 mm and a length "1" of the order from 5 to 15 mm. The retroperfusion cannula 30 also includes a circular ring 34, made of metal or polyurethane, with a diameter D very slightly smaller than the internal diameter D' of the main arterial cannula, allowing the retroperfusion cannula to slide easily. The tube 32 has a proximal end 36 relative to the blood outlet 26 of the main arterial cannula 22, and an opposite, distal end 36'. The ring 34 is located at the proximal end 36 of the tube 32 and is separated from the tube 32 by a cutout 38. The proximal 36 and distal 36' ends are oblique and elliptical.
[0071] The main arterial cannula 22 has a translation portion T ([Fig. 11]) of the ring 34 of identical length to the length “1” of the tube 32.
[0072] The ratio between the internal diameter D' of the main arterial cannula and the internal diameter of the tube 32 of the retroperfusion cannula 30 is 8.
[0073] The retro-perfusion cannula 30 has a wall having a thickness "e" of 0.1 mm.
[0074] An elliptical lumen 26' ([Fig.3]) is present in the bend 27 of the main arterial cannula 22, opposite the blood outlet 26, to allow the retroperfusion cannula 30 to be deployed out of the main arterial cannula 22. The lumen 26' has a shape and dimensions substantially identical to the shape and dimensions of the cross-section of the tube 32. Thus, only the tube 32 in its elliptical portion is suitable for being deployed in the artery through the lumen 26'.
[0075] Figure 3 further shows that the first end 24 of the main arterial cannula 22 has an inner wall 31 against which the tube 32 and the ring 34 of the retroperfusion cannula are configured to slide. Thus, the tube 32 is positioned in contact with the inner wall 31.
[0076] Furthermore, the tube 32 of the retroperfusion cannula 30 has a flexible bulge 33 configured to lock the retroperfusion cannula 30 in the deployed position. The bulge 33 is located on the upper part 32' of the tube 32. It cooperates with the outer and upper part of the lumen 26' of the elbow 27 of the main arterial cannula 22. The bulge 33 prevents spontaneous withdrawal of the retroperfusion cannula 30 from the main arterial cannula.
[0077] The tube 32 is made of biocompatible composite material and includes a portion at the cut 38 in the form of a steel strip.
[0078] Furthermore, as shown in [Fig. 4], the ring 34 may have a rib 52 configured to cooperate with a groove 50 ([Fig. 6]) arranged longitudinally in the inner wall 31 of the main arterial cannula 22. The groove 50 has a length corresponding to the translation length of the retroperfusion cannula 30. Thus, the groove 50 limits and contains the translation of the retroperfusion cannula. It prevents the retroperfusion cannula 30 from escaping from the first end. 24 of the main arterial cannula 22 during the transition from the retracted to the extended position, such that the proximal end 36 of the tube 32 stops precisely within the thickness of the elbow wall 27 of the main arterial cannula 22 in the extended position. Furthermore, it limits the translation of the retroperfusion cannula 30 during the transition from the extended to the retracted position, such that the distal end 36' of the tube 32 stops precisely within the thickness of the elbow wall 27 of the main arterial cannula 22 in the retracted position.
[0079] In an embodiment shown in [Fig. 13], the ring 34 does not have a rib 52 and the inner wall 31 of the main cannula does not have a groove 50. In this embodiment, the main arterial cannula has, outside the translational portion T of the ring 34, an internal diameter smaller than the diameter D of the ring 34 ([Fig. 11]). Thus, the translational portion T has an internal diameter larger than the internal diameter of the rest of the main arterial cannula, the internal diameter of the translational portion T being very slightly larger than the diameter D of the ring. The translation of the ring is limited during the deployment and / or withdrawal of the retroperfusion cannula by the smaller internal diameter of the main arterial cannula outside the translational portion T of the ring. The difference in diameter forms a stop 21 ([Fig. 11]) at each end of the translational portion T.
[0080] As shown in [Fig. 3], the main arterial cannula has an internal protrusion 51. As will be seen later, the internal protrusion 51 is configured to limit the translation of an introduction stylet 40 intended to be inserted into the arterial cannula 20.
[0081] Figures 7 to 11 illustrate a first embodiment of an introduction stylet 40 according to the present description. The introduction stylet is configured to be inserted into an arterial cannula 20 as described above, prior to its insertion into an artery, in order to allow both the insertion of the main arterial cannula 22 into the artery and the deployment of the retroperfusion cannula 30 out of the main arterial cannula 22. It has a pointed proximal end 42, designed to pass through the blood outlet 26 of the main arterial cannula 22 when the introduction stylet 40 is inserted into the arterial cannula, in order to facilitate the insertion of the main arterial cannula 22 into the artery. It further has a clamp-shaped distal end 42', configured to grip the second end 28 of the arterial cannula.
[0082] As shown in [Fig. 7], the introducing stylet 40 advantageously has a first intermediate portion 47, proximal to the proximal end 42, and a second intermediate portion 47', proximal to the distal end 42', shaped like a clamp. The first intermediate portion 47 is slightly longer than the retroperfusion cannula and has a diameter smaller than the diameter of the main arterial cannula. Thus, the first intermediate portion 47 does not spatially interfere with the retroperfusion cannula when the latter is retracted within the main arterial cannula. The second intermediate portion 47', on the other hand, can have a diameter substantially identical to that of the main arterial cannula to minimize play during its insertion into the arterial cannula. Furthermore, this provides some rigidity to the insertion stylet and allows for axial and centered progression during its insertion into the arterial cannula. However, to ensure it remains non-obstructive, the second intermediate portion 47' has longitudinal grooves (not shown) to allow blood flow.
[0083] The proximal end 42 of the introducing stylet 40 has a gradually increasing diameter, up to a maximum diameter D” substantially identical to the internal diameter D' of the main arterial cannula 22, which allows the main arterial cannula 22 to be obstructed. Thus, no blood flow occurs as long as the introducing stylet is positioned within the main arterial cannula. This gradually increasing diameter allows the introducing stylet 40 to be inserted into the first end 24 of the main arterial cannula 20, in which the retroperfusion cannula 30 is positioned in its retracted position. Indeed, the retracted retroperfusion cannula 30 reduces the free internal space of the main arterial cannula (as can be seen in [Fig. 6]).
[0084] Furthermore, the proximal end 42 of the introducing stylet 40 is configured to cooperate with the ring 34 of the retroperfusion cannula. To this end, the proximal end 42 has a groove 44 in which the ring 34 is designed to fit ([Fig. 10]). The groove 44 allows the retroperfusion cannula 30 to be held in a retracted position within the main arterial cannula 22 during insertion of the main arterial cannula 22 into an artery, and to move the retroperfusion cannula 30 into its extended position during withdrawal of the introducing stylet 40 from the arterial cannula 20.
[0085] The proximal end 42 of the introduction stylet 40 is configured to enter against the internal protrusion 51 ([Fig.3]) of the main arterial cannula, at the level of the maximum diameter D”. Thus, the translation of the introduction stylet 40 in the main arterial cannula is limited so that the ring 34 of the retroperfusion cannula fits into the groove 44 of the introduction stylet.
[0086] Figure 8 shows that the insertion stylet 40 may have notches 45 at and around the throat 44. These notches allow the formation of a deformable retention system 49. Thus, when the retroperfusion cannula completes its translation within the main arterial cannula during its deployment, the diameter of the stylet at the level of the deformable retention system contracts slightly. allowing it to slide out of the ring to become completely free of the arterial cannula.
[0087] The introduction mandrel 40 is deformable, so as to be able to give any shape to the main arterial cannula 22. Indeed, the flexible parts of the main arterial cannula 22 are able to be deformed by the introduction mandrel 40, so as to give it for example a Z shape comprising a first free branch corresponding to the first end 24 intended to be introduced into an artery, a central branch 43 and a second free branch 43' intended to cooperate with the oxygenator (not shown).
[0088] As shown in [Fig.9], the feed mandrel 40 is axially perforated in its center into a hollow cylinder 400.
[0089] Figures 12 and 13 illustrate a second embodiment of an infeed mandrel 40' according to the present exposition.
[0090] The introduction stylet 40' has a recess 46 complementary to the tube 32 of the retroperfusion cannula 30 ([Fig. 10]), allowing the introduction stylet 40' to be inserted into the first end 24 of the main arterial cannula 20 in which the retroperfusion cannula 30 is arranged in the retracted position. This recess 46 has a lug 48 configured to cooperate with the tube 32 of the retroperfusion cannula 30 to allow its deployment out of the main arterial cannula 22.
[0091] The introduction stylet 40 according to the first embodiment is symmetrical with respect to its longitudinal axis and is therefore configured to be inserted into the arterial cannula 20 in any position regardless of the rotation of the stylet on its axis.
[0092] On the other hand, the introduction mandrel 40' according to the second embodiment is configured to be inserted into the arterial cannula in a precise position, so that the recess 46 cooperates with the tube 32 of the retro-perfusion cannula 30.
[0093] These mandrels 40, 40' allow bidirectional translation of the retro-perfusion cannula.
[0094] Figures 14 to 1611 to 14 illustrate a retraction stylet 53 configured to allow the retroperfusion cannula 30 to be retracted into the main arterial cannula 22, in order to allow the main arterial cannula 22 to be withdrawn from an artery.
[0095] The retraction stylet 53 is configured to be inserted into an arterial cannula 20 as described above, when the retroperfusion cannula 30 is in the deployed position, in order to allow the retroperfusion cannula 30 to be retracted into the main arterial cannula 22. It has a proximal end 54 in the form of a substantially spherical bulge designed to fit into and conceal the ring 34 of the retroperfusion cannula 30. It further has a first part The retraction stylet has a 54' intermediate section, preferably cylindrical, with a diameter that allows the retroperfusion cannula to be withdrawn without spatial interference during its retraction into the main arterial cannula. This first 54' intermediate section has a length substantially identical to that of the retroperfusion cannula. The retraction stylet also has a second 54' intermediate section, preferably cylindrical, with a diameter substantially equal to that of the main arterial cannula, in order to obstruct it and prevent blood from flowing back into the main arterial cannula. The retraction stylet also has a 54' distal end shaped like a cap, configured to cooperate with the second end 28 of the arterial cannula.
[0096] The second intermediate part 54' ' of the withdrawal mandrel 53 has a diameter substantially identical to the internal diameter D' of the main arterial cannula 22, which allows the main arterial cannula 22 to be obstructed. Thus, no blood flow circulates in the arterial cannula when the withdrawal mandrel is disposed in the main arterial cannula.
[0097] The substantially spherical bulge 54 is configured to cooperate with the ring 34 which has a convex inner wall 34' ([Fig.5]) in order to drive the retro-perfusion cannula 30 in translation in the main arterial cannula 22, when it is inserted into the arterial cannula 20.
[0098] In addition, the convex inner wall 34' of the ring 34 allows the blood flow to be flattened and thus prevents hemolysis and turbulent blood flows.
[0099] As shown in [Fig. 14], the retraction stylet 53 allows the main arterial cannula 22 to be occluded when inserted into the main arterial cannula.
Claims
Claims
1. Arterial cannula (20) for ECMO comprising: - a main arterial cannula (22) having an inner wall (31) and having a first end (24) with a blood outlet orifice (26), the first end being intended to be introduced into an artery (100) in order to inject blood retrogradely into the artery, and - a retroperfusion cannula (30) configured to be movable in translation between a retracted position in the first end of the main arterial cannula and a deployed position at least partly outside the first end of the main arterial cannula, opposite the blood outlet orifice of the main arterial cannula, the retroperfusion cannula comprising a tube (32) of diameter smaller than the diameter of the main arterial cannula and a ring (34) of diameter substantially identical to the diameter of the main arterial cannula,disposed at a proximal end of the retroperfusion cannula relative to the blood outlet orifice of the main arterial cannula.,
2. An arterial cannula according to claim 1, having an L-shape with a first branch corresponding to the first end intended to be introduced into the artery, and a second branch intended to cooperate with an oxygenator, the first branch and the second branch being connected by an elbow (27).
3. An arterial cannula according to any preceding claim, wherein the retroperfusion cannula is configured to slide in translation in contact with the inner wall of the main arterial cannula, until the ring comes into contact with a stop (21) of the inner wall.
4. An arterial cannula according to any preceding claim, wherein a cutout (38) is present between the tube and the ring.
5. An arterial cannula according to any preceding claim, wherein the tube has an elliptical profile.
6. An arterial cannula according to any preceding claim, wherein the ring has a convex inner wall (34').
7. An arterial cannula according to any preceding claim, wherein the main arterial cannula has a longitudinal groove (50) at its inner wall cooperating with a rib (52) disposed on the ring of the retroperfusion cannula.
8. An arterial cannula according to any preceding claim, wherein the main arterial cannula has a translation portion (T) of the ring (34) having an internal diameter greater than the internal diameter of the remainder of the main arterial cannula.
9. An introducer mandrel (40, 40') configured to be inserted into the arterial cannula of any preceding claim, to enable both insertion of the main arterial cannula into an artery and deployment of the retroperfusion cannula out of the main arterial cannula, the introducer mandrel being configured to occlude the main arterial cannula.
10. Introduction mandrel (40, 40') according to the preceding claim, comprising a proximal end (42) configured to be arranged in the first end of the main arterial cannula, the proximal end (42) having a diameter increasing up to a diameter substantially identical to the diameter of the main arterial cannula, the proximal end (42) being followed by a first intermediate portion (47) of length at least greater than that of the retroperfusion cannula and of diameter less than the diameter of the main arterial cannula, the first intermediate portion (47) being followed by a second intermediate portion (47') of diameter substantially identical to that of the main arterial cannula.
11. A withdrawal mandrel (53) configured to be inserted into the arterial cannula of any one of claims 1 to 8, to allow the retroperfusion cannula to be retracted into the main arterial cannula, to allow the main arterial cannula to be withdrawn from the artery, the withdrawal mandrel being configured to occlude the main arterial cannula.
12. A kit comprising an arterial cannula according to any one of claims 1 to 8, an insertion mandrel according to any one of claims 9 to 10 and a withdrawal mandrel according to claim 11.
